Independent research on the U.S. markets, Baptista Research

Baptista Research

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. 

We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

Universal Health Services B / Equity Bottom-Up

<ul><li>Universal Health Services delivered a quarter characterized by resilient operational execution, disciplined expense management, and accelerating investment in outpatient behavioral health capabilities, although several underlying trends suggest that growth remains dependent on improving utilization and continued reimbursement support.</li><li>Revenue growth of 9.6%, adjusted EBITDA growth of 8.4%, and adjusted EPS growth of 16.1% reflected stable pricing trends, strong cost control, and supplemental payment contributions, while same-facility acute care admissions remained flat due to softer flu-related demand and weather disruptions during the quarter.</li><li>Management indicated that acute care volumes were negatively affected by approximately 200 basis points from reduced respiratory activity and adverse weather conditions, though higher-acuity service lines such as cardiology, orthopedics, and neurology showed positive momentum.</li></ul>

Universal Health Services delivered a quarter characterized by resilient operational execution, disciplined expense management, and accelerating investment in outpatient behavioral health capabilities, although several underlying trends suggest that growth remains dependent on improving utilization and continued reimbursement support.Revenue growth of 9.6%, adjusted EBITDA growth of 8.4%, and adjusted EPS growth of 16.1% reflected stable pricing trends, strong cost control, and supplemental payment contributions, while same-facility acute care admissions remained flat due to softer flu-related demand and weather disruptions during the quarter.Management indicated that acute care volumes were negatively affected by approximately 200 basis points from reduced respiratory activity and adverse weather conditions, though higher-acuity service lines such as cardiology, orthopedics, and neurology showed positive momentum.

Universal Health Services: 7.3% Behavioral Health Growth Masks Flat Acute Care Volumes!